These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11356080)

  • 1. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
    Sung RS; Qin L; Bromberg JS
    Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression.
    Vassalli G; Agah R; Qiao R; Aguilar C; Dichek DA
    Circ Res; 1999 Oct; 85(9):e25-32. PubMed ID: 10532959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
    Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
    J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors.
    Everett RS; Evans HK; Hodges BL; Ding EY; Serra DM; Amalfitano A
    Virology; 2004 Jul; 325(1):96-105. PubMed ID: 15231389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression.
    Michou AI; Santoro L; Christ M; Julliard V; Pavirani A; Mehtali M
    Gene Ther; 1997 May; 4(5):473-82. PubMed ID: 9274725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
    Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
    Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
    Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
    J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
    Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
    Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
    Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
    Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and adaptive immune response to intracellular transgenes delivered by helper-dependent vs. first generation adenoviral vectors.
    Mian A; Guenther M; Finegold M; Ng P; Rodgers J; Lee B
    Mol Genet Metab; 2005 Mar; 84(3):278-88. PubMed ID: 15694178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P; Tian J; Kovesdi I; Bruder JT
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
    Cheng J; Sun J; Sung RS
    Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained expression of human apo A-I following adenoviral gene transfer in mice.
    De Geest B; Van Linthout S; Collen D
    Gene Ther; 2001 Jan; 8(2):121-7. PubMed ID: 11313781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
    Tai KF; Chen PJ; Chen DS; Hwang LH
    J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus.
    Stein CS; Pemberton JL; van Rooijen N; Davidson BL
    Gene Ther; 1998 Apr; 5(4):431-9. PubMed ID: 9614566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
    Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
    Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.